Table 2.

Co-morbid conditions and concomitant treatments in relation to late rectal and bladder toxicity.

Co-morbid conditions	Patients (%)	Rectal tox. 0 vs. >0.		Bladder tox. 0 vs. >0
		Chi value	p	Chi value	p
Diabetes	46 (17.9)	0.020	0.886	0.195	0.659
Hypertension	102 (39.7)	0.243	0.622	0.486	0.490
Collagens diseases	3 (1.2)	0.006	0.937	0	0.993
Abdominal surgery a	107 (41.6)	2.471	0.480	1.829	0.609
Arteriopathy b	33 (12.8)	0.278	0.598	0.027	0.868
Inflammatory bowel disease	2 (0.8)	0.948	0.330	0.507	0.477
Benign anal pathology	21 (8.2)	0.077	0.781	0.445	0.505
Smoking habit
Active smoking	60 (23.3)	0.054	0.82	0.012	0.913
Pharmacological treatments
Anticoagulantsc	19 (7.4)	6.099	0.014	0.123	0.726
Antiaggregantsd	35 (13.6)	0.049	0.824	0.789	0.374
Androgen deprivation e	170 (66.1)	0.235	0.628	1.176	0.278
Chemotherapy	1 (0.4)	0.271	0.603	0.252	0.616

^aAbdominal surgery includes intra and extra-peritonial surgery.

^bIncluded ischemic heart disease.

^cIncludes acenocumarol treatment.

^dIncludes aspirin and clopidogrel.

^eIncludes bicalutamide and/or LH-RH analogs.